Cargando…
LncRNA‐AK137033 inhibits the osteogenic potential of adipose‐derived stem cells in diabetic osteoporosis by regulating Wnt signaling pathway via DNA methylation
OBJECTIVES: Bone tissue engineering based on adipose‐derived stem cells (ASCs) is expected to become a new treatment for diabetic osteoporosis (DOP) patients with bone defects. However, compared with control ASCs (CON‐ASCs), osteogenic potential of DOP‐ASCs is decreased, which increased the difficul...
Autores principales: | Peng, Shuanglin, Gao, Yujin, Shi, Sirong, Zhao, Dan, Cao, Huayue, Fu, Ting, Cai, Xiaoxiao, Xiao, Jingang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780896/ https://www.ncbi.nlm.nih.gov/pubmed/34953002 http://dx.doi.org/10.1111/cpr.13174 |
Ejemplares similares
-
JKAMP inhibits the osteogenic capacity of adipose-derived stem cells in diabetic osteoporosis by modulating the Wnt signaling pathway through intragenic DNA methylation
por: Peng, Shuanglin, et al.
Publicado: (2021) -
Downregulation of DNA methyltransferase-3a ameliorates the osteogenic differentiation ability of adipose-derived stem cells in diabetic osteoporosis via Wnt/β-catenin signaling pathway
por: Zhang, Maorui, et al.
Publicado: (2022) -
LncRNA AK023948 is a positive regulator of AKT
por: Koirala, Pratirodh, et al.
Publicado: (2017) -
LncRNA AK054921 and AK128652 are potential serum biomarkers and predictors of patient survival with alcoholic cirrhosis
por: Yang, Zhihong, et al.
Publicado: (2017) -
LncRNA DANCR and miR-320a suppressed osteogenic differentiation in osteoporosis by directly inhibiting the Wnt/β-catenin signaling pathway
por: Wang, Cheng-Gong, et al.
Publicado: (2020)